Cure My Disease

Don't miss your cure!

 Log in / Sign up

New hearing aid algorithm aims to cut through noise for clearer speech

NCT ID NCT07700043

Not yet recruiting Symptom relief Sponsor: NYU Langone Health Source: ClinicalTrials.gov ↗

First seen Jul 13, 2026 · Last updated Jul 14, 2026 · Updated 1 time

Summary

This study tests a new hearing aid algorithm called SEDA-HA designed to help people with hearing loss understand speech better in noisy environments. Participants aged 16 and older with mild to severe bilateral sensorineural hearing loss will use a prototype hearing aid with the algorithm for 30 days at home. Researchers will measure how many words they can repeat in different background noises and whether they prefer the algorithm on or off.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
SEDA-HA algorithm (hearing aid device)
What this could lead to
If successful, this algorithm could help people with hearing loss understand speech better in noisy places like restaurants or traffic.
What could go wrong
This is a small, early-stage study with 60 participants. The algorithm may not work well for all types of hearing loss or in all real-world settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BILATERAL SENSORINEURAL HEARING LOSS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hearing loss disorder sensorineural hearing loss disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BILATERAL SENSORINEURAL HEARING LOSS

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • NYU Langone Health

    New York, New York, 10016, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.